
Eli Avisar MD
Breast, Hepatobiliary Surgery, Melanoma, Surgical Oncology (Other than Breast)
Professor, Surgery, University of Miami School of Medicine
Join to View Full Profile
1611 NW 12th Ave# M851Miami, FL 33136
Phone+1 305-585-1288
Fax+1 305-243-8470
Dr. Avisar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Eli Avisar is a general surgeon in Miami, FL and is affiliated with multiple hospitals in the area, including Jackson Health System, University of Miami Hospital, and University of Miami Hospital and Clinics. He received his medical degree from The Hebrew University of Jerusalem Hadassah Medical School and has been in practice 27 years. He specializes in breast, hepatobiliary surgery, melanoma, and surgical oncology (other than breast) and is experienced in esophageal cancer, gastric cancer, breast reconstruction, breast surgery, and head and neck oncology and microvascular reconstruction.
Education & Training
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Surgery, 1994 - 1998
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1990
Hebrew UniversityB.Sc., Medical Sciences, with Honors, 1985
Certifications & Licensure
FL State Medical License 2003 - 2027
PA State Medical License 1999 - 2006
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer Start of enrollment: 2004 May 01
- Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction Start of enrollment: 2010 Mar 16
- MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- ASO Visual Abstract: Prognostic Value of Non-Nodal Regional Metastases in Predicting Sentinel Lymph Node Status in Cutaneous Melanoma: Multicenter Analysis of the Sent...Nazia Riaz, Stanley P Leong, Mohammed Kashani-Sabet, Richard L White Jr, John T Vetto
Annals of Surgical Oncology. 2026-02-26 - Publisher Correction: Prognostic Value of Non-nodal Regional Metastases in Predicting Sentinel Lymph Node Status in Cutaneous Melanoma: Multicenter Analysis of the Sen...Nazia Riaz, Stanley P Leong, Mohammed Kashani-Sabet, Richard L White Jr, John T Vetto
Annals of Surgical Oncology. 2026-02-16 - Prognostic Value of Non-nodal Regional Metastases in Predicting Sentinel Lymph Node Status in Cutaneous Melanoma: Multicenter Analysis of the Sentinel Lymph Node Worki...Nazia Riaz, Stanley P Leong, Mohammed Kashani-Sabet, Richard L White Jr, John T Vetto
Annals of Surgical Oncology. 2026-01-23
Journal Articles
- Internal Mammary Node Irradiation: Does One Treatment Fit All?E. Avisar, J Clin Oncol, 1/23/2016
- A rare complication resulting in a rare disease: radiation-induced male breast cancerJ. Alazhri, C. Saclarides and E. Avisar, BMJ Case Rep, 1/15/2016
- S. Libson, S. Rodgers, V. Koshenkov, J. Hurley and E. Avisar, International Journal of Surgery Open, 1/1/2016
Books/Book Chapters
Abstracts/Posters
- Identifying the Low-risk Subgroups Among Intermediate Thickness Melanoma PatientsJ. M. Chang, H. E. Kosiorek, A. C. Dueck, S. P. L. Leong, J. T. Vetto, R. L. White, E. Avisar, J. S. Zager, C. Garberoglio and B. A. Pockaj, Society of Surgical Oncology, Boston, MA, 1/1/2016
- Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Can We Improve Survival with Less Postoperative Complications?O. Picado, C.I. Ripat, R. Vega, G.J. Tiesi, E.A. Paulus, L. Sanchez, H. Bahna, F. Marchetti, E. Avisar, D. Franceschi, A.S. Livingstone, D. Yakoub and M. G. Moller, Society of Surgical Oncology, Boston, MA, 1/1/2016
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Provides a Survival Benefit in Unresectable Peritoneal CarcinomatosisC.I. Ripat, O. Picado, G.J. Tiesi, H. Bahna, F. Marchetti, E. Avisar, D. Franceschi, A.S. Livingstone, D. Yakoub and M. G. Moller, 11th International Symposium on Regional Cancer Therapies, Chandler, AZ, 1/1/2016
Lectures
- Long-Term Survival Based on Pathologic Response to Neoadjuvant Therapy in Esophageal CancerSan Diego, CA - 1/1/2016
- Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Can We Improve Survival With Less Postoperative Complications?Chandler, AZ - 1/1/2016
- The Role of Gynecologist Facing Breast CancerAcapulco, Mexico - 1/1/2015
Press Mentions
Sylvester Comprehensive Cancer Center at the Leading Edge of Breast Cancer Research and TreatmentOctober 1st, 2025
Sylvester Breast Cancer Surgeon Finds Simple Procedure Sharply Reduces LymphedemaDecember 15th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









